UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 200

Sortiert nach

The BMP-2 mutant L51P: a BMP receptor IA binding-deficient inhibitor of noggin

Journal of bone and mineral metabolism, 2019-03, Vol.37 (2), p.199-205

2019

Volltextzugriff (PDF)

N-terminal specificity of PEGylation of human bone morphogenetic protein-2 at acidic pH

International journal of pharmaceutics, 2011-07, Vol.413 (1), p.140-146

2011

Volltextzugriff (PDF)

Receptor oligomerization and beyond: a case study in bone morphogenetic proteins

BMC biology, 2009-09, Vol.7 (1), p.59-59, Article 59

2009

Volltextzugriff (PDF)

The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling Pathways

The Journal of biological chemistry, 2002-02, Vol.277 (7), p.5330-5338

2002

Volltextzugriff (PDF)

Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing

Journal of bone and mineral metabolism, 2009, Vol.27 (3), p.355-363

2009

Volltextzugriff (PDF)

Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificity

The EMBO journal, 2009-04, Vol.28 (7), p.937-947

2009

Volltextzugriff (PDF)

GDF-5 can act as a context-dependent BMP-2 antagonist

BMC biology, 2015-09, Vol.13 (1), p.77-77, Article 77

2015

Volltextzugriff (PDF)

Crystal structure of the BMP-2-BRIA ectodomain complex

Nature structural & molecular biology, 2000-06, Vol.7 (6), p.492-496

2000

Volltextzugriff (PDF)

Crystal Structure Analysis Reveals How the Chordin Family Member Crossveinless 2 Blocks BMP-2 Receptor Binding

Developmental cell, 2008-05, Vol.14 (5), p.739-750

2008

Volltextzugriff (PDF)

Molecular recognition of BMP-2 and BMP receptor IA

Nature structural & molecular biology, 2004-05, Vol.11 (5), p.481-488

2004

Volltextzugriff (PDF)

Utilizing BMP-2 muteins for treatment of multiple myeloma

PloS one, 2017-05, Vol.12 (5), p.e0174884-e0174884

2017

Volltextzugriff (PDF)

von Willebrand Factor Type C Domain-containing Proteins Regulate Bone Morphogenetic Protein Signaling through Different Recognition Mechanisms

The Journal of biological chemistry, 2007-07, Vol.282 (27), p.20002-20014

2007

Volltextzugriff (PDF)

Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand

The FEBS journal, 2008-01, Vol.275 (1), p.172-183

2008

Volltextzugriff (PDF)

Crossveinless 2 is an essential positive feedback regulator of Bmp signaling during zebrafish gastrulation

Development (Cambridge), 2006-03, Vol.133 (5), p.801-811

2006

Volltextzugriff (PDF)

The BMP2 antagonist inhibitor L51P enhances the osteogenic potential of BMP2 by simultaneous and delayed synergism

Bone (New York, N.Y.), 2014-12, Vol.69, p.165-173

2014

Volltextzugriff (PDF)

Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids

Journal of leukocyte biology, 2007-01, Vol.81 (1), p.336-343

2007

Volltextzugriff (PDF)

Structure, binding, and antagonists in the IL-4/IL-13 receptor system

BBA - Molecular Cell Research, 2002-11, Vol.1592 (3), p.237-250

2002

Volltextzugriff (PDF)

Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction

Biological chemistry, 2004-08, Vol.385 (8), p.697-710

2004

Volltextzugriff (PDF)

Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN

PLoS genetics, 2009-11, Vol.5 (11), p.e1000747-e1000747

2009

Volltextzugriff (PDF)

In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments

Clinical orthopaedics and related research, 2006-02, Vol.443, p.113-123

2006

Volltextzugriff (PDF)

Structure Analysis of Bone Morphogenetic Protein-2 Type I Receptor Complexes Reveals a Mechanism of Receptor Inactivation in Juvenile Polyposis Syndrome

The Journal of biological chemistry, 2008-02, Vol.283 (9), p.5876-5887

2008

Volltextzugriff (PDF)

Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors

Molecular biology of the cell, 2000-03, Vol.11 (3), p.1023-1035

2000

Volltextzugriff (PDF)

Binding between Crossveinless-2 and Chordin von Willebrand factor type C domains promotes BMP signaling by blocking Chordin activity

PloS one, 2010-09, Vol.5 (9), p.e12846-e12846

2010

Volltextzugriff (PDF)

Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3

Nature medicine, 2013-07, Vol.19 (7), p.809

2013

Volltextzugriff (PDF)

A selection fit mechanism in BMP receptor IA as a possible source for BMP ligand-receptor promiscuity

PloS one, 2010-09, Vol.5 (9), p.e13049

2010

Volltextzugriff (PDF)

1 – 25 von 200

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(161)

Publikationsform

Sprache

Englisch
(194)
Japanisch
(40)
Deutsch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The BMP-2 mutant L51P: a BMP receptor IA binding-deficient inhibitor of noggin

N-terminal specificity of PEGylation of human bone morphogenetic protein-2 at acidic pH

Receptor oligomerization and beyond: a case study in bone morphogenetic proteins

The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling Pathways

Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing

Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificity

GDF-5 can act as a context-dependent BMP-2 antagonist

Crystal structure of the BMP-2-BRIA ectodomain complex

Crystal Structure Analysis Reveals How the Chordin Family Member Crossveinless 2 Blocks BMP-2 Receptor Binding

Molecular recognition of BMP-2 and BMP receptor IA

Utilizing BMP-2 muteins for treatment of multiple myeloma

von Willebrand Factor Type C Domain-containing Proteins Regulate Bone Morphogenetic Protein Signaling through Different Recognition Mechanisms

Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand

Crossveinless 2 is an essential positive feedback regulator of Bmp signaling during zebrafish gastrulation

The BMP2 antagonist inhibitor L51P enhances the osteogenic potential of BMP2 by simultaneous and delayed synergism

Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids

Structure, binding, and antagonists in the IL-4/IL-13 receptor system

Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction

Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN

In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments

Structure Analysis of Bone Morphogenetic Protein-2 Type I Receptor Complexes Reveals a Mechanism of Receptor Inactivation in Juvenile Polyposis Syndrome

Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors

Binding between Crossveinless-2 and Chordin von Willebrand factor type C domains promotes BMP signaling by blocking Chordin activity

Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3

A selection fit mechanism in BMP receptor IA as a possible source for BMP ligand-receptor promiscuity

Suchergebnisse filtern